SEPN
SEPN
NASDAQ · Pharmaceuticals

Septerna Inc

$23.97
-0.24 (-0.99%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +87.6% upside
Low Target $33.78
Average Target $44.96
High Target $58.81
Current Price $23.97
Current
$23.97
Target
$44.96
$33.78 $44.96 avg $58.81
Scenario Analysis
Bear Case
$33.78
40.9%
Low target
Base Case
$44.96
+87.6%
Avg target
Bull Case
$58.81
+145.3%
High target
Risk/Reward
3.6x
Highly favorable
Price in Context
52-Week High
$31.37
-23.6% from high
52-Week Low
$4.66
+414.4% from low
Target vs 52W High
$44.96
+43.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%